Eczema causes dry and itchy skin and affects one in five children in the UK. Treatment regimes for children with eczema are time consuming and can be confusing in terms of what to do when and how to apply treatments. As a result, treatment adherence is often poor. If treatments are not applied correctly, the eczema can worsen and affect the quality of life of the child and their family.
Written action plans (WAPs) are a set of instructions, specific to a patient, on how to look after their condition. They have been successful in the treatment of asthma, another long-term condition that is common in children.
The research team, led by Dr Matthew Ridd, developed the tool as part of a study in which they explored, with parents and health professionals, the potential of a WAP for improving treatment adherence in childhood eczema. The study, published in the British Journal of General Practice today, identified several challenges that the eWAP has been designed to address, including:
- parental confusion about treatment application
- lack of verbal and written advice from GPs
- differing beliefs about the cause and management of eczema
- re-prescribing or failed treatments
- parents feeling unsupported by their GPs.
Dr Ridd said: “Both parents and healthcare professionals thought a WAP for eczema was a good idea and would help address the challenges identified in our study. Although GPs had some concerns about fitting it in with other competing priorities, there was general agreement that it could be a useful educational tool, increasing parents’ knowledge and confidence in managing eczema at home, and possibly reducing consultations.
“We have made the eWAP freely available to parents, doctors and nurses for clinical use and would like to encourage interested parents and clinicians to download it, use it and let us know how they get on. We have tried to make it as user-friendly as possible, using pictures and a colourful design to make it easy to use and understand. The next step for the research team is to evaluate the WAP, possibly in a clinical trial, to see if it leads to better controlled eczema when used by families.”
The eWAP is available in Word and PDF formats from www.bristol.ac.uk/ewap. It includes a section for individualised guidance on treatment, using a simple stepped approach, and general information about eczema, its potential triggers and how to manage problem symptoms. It also provides links to useful resources, such as videos which show how to apply moisturisers correctly.